Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/7/2025

Mumps-Related Orchitis and Parotitis

  • Orchitis is a well-established complication of mumps infection, occurring in up to 38% of postpubertal males who develop mumps, with parotitis typically preceding orchitis by an average of 10 days 1, 2
  • The Centers for Disease Control and Prevention recommends that clinicians recognize the relationship between mumps and orchitis, as serious complications can occur without evidence of parotitis 1, 2

Clinical Presentation and Diagnosis

  • The typical sequence of mumps-related orchitis follows a predictable pattern, with initial phase bilateral or unilateral parotitis developing 16-18 days after mumps virus exposure, often preceded by fever, headache, malaise, myalgia, and anorexia 1, 2
  • The American Academy of Pediatrics notes that only 60-70% of mumps infections actually produce parotitis, while 15-20% are asymptomatic and up to 50% present with nonspecific respiratory symptoms 3
  • Viral orchitis is most frequently ascribed to mumps virus, diagnosed by IgM serology for mumps antibodies or acute and convalescent IgG serology 5, 6

Epidemiology and Prevention

  • The incidence of orchitis increases dramatically after puberty, affecting up to 38% of postpubertal males with mumps but is rare in prepubertal boys 1, 2, 4
  • The Centers for Disease Control and Prevention recommends two-dose MMR vaccine effectiveness, which is approximately 88%, though breakthrough infections can still occur 7, 3